Comprehensive metabolomic profiling of plasma from patients (pts) with metastatic urothelial carcinoma (mUC) receiving immune checkpoint inhibitors (ICI) or platinum-based chemotherapy (PBC).

Talal El Zarif, Guru Sonpavde, Praful Ravi et al.|Journal of Clinical Oncology|2022

Cited by 1